BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 20610572)

  • 1. PDGF beta-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL.
    Getachew R; Ballinger ML; Burch ML; Reid JJ; Khachigian LM; Wight TN; Little PJ; Osman N
    Endocrinology; 2010 Sep; 151(9):4356-67. PubMed ID: 20610572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor-stimulated versican synthesis but not glycosaminoglycan elongation in vascular smooth muscle is mediated via Akt phosphorylation.
    Osman N; Getachew R; Thach L; Wang H; Su X; Zheng W; Little PJ
    Cell Signal; 2014 May; 26(5):912-6. PubMed ID: 24462709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo.
    Ballinger ML; Osman N; Hashimura K; de Haan JB; Jandeleit-Dahm K; Allen T; Tannock LR; Rutledge JC; Little PJ
    J Cell Mol Med; 2010 Jun; 14(6B):1408-18. PubMed ID: 19754668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genistein inhibits PDGF-stimulated proteoglycan synthesis in vascular smooth muscle without blocking PDGFβ receptor phosphorylation.
    Little PJ; Getachew R; Rezaei HB; Sanchez-Guerrero E; Khachigian LM; Wang H; Liao S; Zheng W; Ballinger ML; Osman N
    Arch Biochem Biophys; 2012 Sep; 525(1):25-31. PubMed ID: 22683649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of Ki11502 as a potent inhibitor of PDGF beta receptor-mediated proteoglycan synthesis in vascular smooth muscle cells.
    Getachew R; Ballinger ML; Burch ML; Little PJ; Osman N
    Eur J Pharmacol; 2010 Jan; 626(2-3):186-92. PubMed ID: 19818754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor.
    Dahring TK; Lu GH; Hamby JM; Batley BL; Kraker AJ; Panek RL
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1446-56. PubMed ID: 9190882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib mesylate stimulates low-density lipoprotein receptor-related protein 1-mediated ERK phosphorylation in insulin-producing cells.
    Fred RG; Boddeti SK; Lundberg M; Welsh N
    Clin Sci (Lond); 2015 Jan; 128(1):17-28. PubMed ID: 24865476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner.
    Wilson PG; Thompson JC; Webb NR; de Beer FC; King VL; Tannock LR
    Am J Pathol; 2008 Dec; 173(6):1902-10. PubMed ID: 18974302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrido-pyrimidine derivative CYC10424 inhibits glycosaminoglycan changes on vascular smooth muscle-derived proteoglycans and reduces lipoprotein binding.
    Ballinger ML; Osman N; Wilks AF; Su S; Burns CJ; Bu X; Little PJ
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):403-12. PubMed ID: 19033819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells.
    Li L; Blumenthal DK; Masaki T; Terry CM; Cheung AK
    J Cell Biochem; 2006 Dec; 99(6):1553-63. PubMed ID: 16817200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suramin inhibits PDGF-stimulated receptor phosphorylation, proteoglycan synthesis and glycosaminoglycan hyperelongation in human vascular smooth muscle cells.
    Little PJ; Rostam MA; Piva TJ; Getachew R; Kamato D; Guidone D; Ballinger ML; Zheng W; Osman N
    J Pharm Pharmacol; 2013 Jul; 65(7):1055-63. PubMed ID: 23738733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.
    Fager G; Camejo G; Olsson U; Ostergren-Lundén G; Lustig F; Bondjers G
    J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (dasatinib).
    Chen Z; Lee FY; Bhalla KN; Wu J
    Mol Pharmacol; 2006 May; 69(5):1527-33. PubMed ID: 16436588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDGF-induced glycosaminoglycan synthesis is mediated via phosphatidylinositol 3-kinase.
    Liu J; Fitzli D; Liu M; Tseu I; Caniggia I; Rotin D; Post M
    Am J Physiol; 1998 May; 274(5):L702-13. PubMed ID: 9612285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
    Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucosamine enhances platelet-derived growth factor-induced DNA synthesis via phosphatidylinositol 3-kinase pathway in rat aortic smooth muscle cells.
    Sato A; Sasaoka T; Yamazaki K; Nakamura N; Temaru R; Ishiki M; Takata M; Kishida M; Wada T; Ishihara H; Usui I; Urakaze M; Kobayashi M
    Atherosclerosis; 2001 Aug; 157(2):341-52. PubMed ID: 11472733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein selectively inhibits platelet-derived growth factor-stimulated versican biosynthesis in monkey arterial smooth muscle cells.
    Schönherr E; Kinsella MG; Wight TN
    Arch Biochem Biophys; 1997 Mar; 339(2):353-61. PubMed ID: 9056268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (S)-[6]-Gingerol inhibits TGF-β-stimulated biglycan synthesis but not glycosaminoglycan hyperelongation in human vascular smooth muscle cells.
    Kamato D; Babaahmadi Rezaei H; Getachew R; Thach L; Guidone D; Osman N; Roufogalis B; Duke CC; Tran VH; Zheng W; Little PJ
    J Pharm Pharmacol; 2013 Jul; 65(7):1026-36. PubMed ID: 23738730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDL.
    Ballinger ML; Ivey ME; Osman N; Thomas WG; Little PJ
    Atherosclerosis; 2009 Aug; 205(2):451-7. PubMed ID: 19217622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDGF-BB-mediated activation of p42(MAPK) is independent of PDGF beta-receptor tyrosine phosphorylation.
    Cartel NJ; Liu J; Wang J; Post M
    Am J Physiol Lung Cell Mol Physiol; 2001 Oct; 281(4):L786-98. PubMed ID: 11557582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.